The California cannabis nursery license may offer an important advantage for companies looking to design the next big cannabis strain.

California is the epicenter of the US cannabis industry, the world’s largest regulated market for both medical and adult-use cannabis. After generating sales of US$2.5 billion in 2018, California’s cannabis market is expected to be generating US$6.5 billion per year by 2025.

For those cannabis companies adopting a vertically integrated business model, the Golden State represents a significant opportunity. There is a growing trend of cannabis companies increasing their market footprint through distribution deals. However, few cannabis companies have recognized the importance of the cannabis nursery for providing a long-term path to increased market share statewide. For cannabis companies looking to carve out a competitive advantage, the cannabis nursery license offers the ability to design and cultivate unique strains capable of differentiating themselves from the competition.

This INNspired Article is brought to you by:

Next Green Wave (CSE:NGW, OTCQB:NXGWF) is a vertically integrated seed to consumer producer and reseller of cannabis products and is building a world-class business and innovating a premium portfolio of brands in California.Send me an Investor Kit

A highly competitive marketplace

Like most emerging marketplaces, California’s cannabis industry is experiencing some understandable growing pains, including oversupply and unwanted competition from black market operators.

The California state Cannabis Advisory Committee’s 2018 annual report noted that the black market in California continues to compete with licensed businesses. “Lack of enforcement is creating a thriving environment for the unregulated ‘underground market,’” said the report’s authors. Around 80 percent of cannabis sold in California originates within the black market, according to estimates by New Frontier Data. The Los Angeles Times reports that California’s cannabis black market was valued at more than four times the size of the legal market in 2018.

Following the legalization of adult-use cannabis last year, California’s licensed cultivators are facing another dilemma common in today’s early-stage cannabis industry: an oversupplied market. As we’ve seen in Washington, Colorado, Oregon, and now in California, more and more cultivators are in a race to produce large quantities of cannabis flower in the hopes of establishing a large footprint. The Sacramento Bee reports that there are more than 1,142 acres of licensed cannabis farms in California. According to a report by the California Department of Food and Agriculture, the state produces 15.5 million pounds of cannabis annually, but only consumes 2.5 million.

Cannabis strains standing out

The most effective strategy to secure market share in a highly competitive environment like this has more to do with quality than quantity. This is especially true in an oversaturated marketplace. And, as with any consumer product, there is a sizable segment of the consumer base that is willing to pay a premium for higher quality products. Cannabis companies with a strong focus on consumer experience and the development of high-quality cannabis strains could be best positioned to compete with their black market rivals.

Companies with vertically integrated operations and a focus on superior genetics have the potential to greatly differentiate their products from the competition. Controlling the entire supply chain from seed to sale gives cannabis companies a high level of control over product quality. In this way, vertical integration enables companies to target specific customer profiles, generating a higher rate of return with each strain and product design.

“A key difference is that we are able to better control the quality of the product at all stages, customers can rest assured that their products have been lab-tested and are of a high quality and consistency. We are also working on providing users with a unique customer experience via products that are of a high quality specifically designed for their needs,” Mike Jennings, COO and Head of Research and Innovation at Next Green Wave (CSE:NGW,OTCQX:NXGWF), told the Investing News Network (INN).

Fortunately, the state’s regulatory framework allows for this strategy. California’s Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) permits companies to hold more than one license type and build vertically integrated business models. Cannabis companies who have recognized this opportunity are strategically adding verticals to their businesses, including nurseries, cultivation facilities, extraction labs and distribution networks. Next Green Wave holds multiple licenses in California including nursery, cultivation, volatile and non-volatile extraction and distribution. Together, the licenses allow the company to fulfill its mission to provide a seed-to-consumer experience to the California cannabis market.

Cannabis strain genetics: another key differentiator

Strain selection and cannabis genetics are critical to premium cannabis brands. Consumers and downstream users routinely seek out consistent, top quality strains. There are more than 25,000 known genes in the cannabis plant and the effects, potency, aroma and flavors that define them are all determined by these genetic traits. Each strain has its own profile, offering a unique experience when compared to other cannabis crops. In order to craft the optimal cannabis consumption experience, cultivators attempt to match genetics with the desired effects, enhancing the end product with customized cultivation practices in controlled environments. These selectively crafted cannabis products are known to fetch premium prices even in the most challenging of markets.

The genetic profile of a cannabis strain and a dedication to superior cultivation methods can also influence the quality of downstream products such as extracts and edibles. “The strain determines the taste, strength, quality and consistency of the product. What you put in is what you get out, so quality and integrity of the product is key. We don’t use bulk trim in our process, and focus on strains that produce the highest quality trichome heads and buds,” said Mike Jennings, six-time Cannabis Cup High Times award winner and co-founder of Loud Seeds, one of the top seed banks in High Times’ Seed Bank Hall of Fame.

Importance of the nursery in the cannabis industry value chain

Companies with a strong focus on genetics are also in a better position to develop new proprietary strains and supply clones, seeds and seedlings to third-party growers. California companies wanting to integrate this segment of the cannabis value chain into their business need a nursery license. Under the state’s cannabis cultivation regulations, nursery facilities are allowed to develop genetics for new plant varieties and to produce clones, immature plants and seeds for either medical or adult-use cannabis. A nursery license also allows the holder to sell those plants and seeds to another state cannabis license holder, including other nurseries, cultivators and processors.

Competing against the black market in California could require licensed cannabis businesses to offer unique strains that appeal to discerning customers. Nurseries are key to answering the increased need for diversified starter material in California’s cannabis industry. Unique, proprietary strains could help set brands apart from not only the black market but from their competitors in the legal landscape as well.

“Our nursery business is key to our supply chain, allowing for the development of new hybrid cannabis strains,” said Jennings. “We’ve curated a massive seed library of 120 strains, including several award-winning genetics and cultivars.”

Next Green Wave recently signed a licensing agreement with Intrexon Corporation (NASDAQ:XON) to use the Botticelli tissue culturing technology platform in the production of Next Green Wave’s proprietary cannabis cultivars. Tissue culture propagation enables the efficient production of pathogen-free, genetically consistent plantlets in a more sustainable and scalable method than conventional cloning methods. “This program enables Next Green Wave to improve its library of award-winning premium genetics and ensure that all of our flowering facilities are filled with the highest quality of nursery stock resulting in higher yields and overall cannabinoid content than traditional clones,” said Jennings. In addition to using these cannabis plantlets for its own downstream products, Next Green Wave plans to sell nursery stock to other commercial growers as well.


Cannabis companies that can provide top-shelf strains designed to enhance customer experience could be in an optimal position to compete with the black market and other licensed producers. In a highly competitive marketplace, the cannabis nursery license allows companies to serve discerning customers by offering a portfolio of premium proprietary cannabis strains, enabling cultivators to stand out in an increasingly crowded marketplace.

Disclaimer* This INNSpired article is sponsored by Next Green Wave (CSE:NGW,OTCQX:NXGWF). This INNSpired article provides information which was sourced by the Investing News Network (INN) and approved by Next Green Wave in order to help investors learn more about the company. Next Green Wave is a client of INN. The company’s campaign fees pay for INN to create and update this INNSpired article.

This INNSpired article was written according to INN editorial standards to educate investors.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with Next Green Wave and seek advice from a qualified investment advisor.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less